- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 235/16 - Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Patent holdings for IPC class C07D 235/16
Total number of patents in this class: 185
10-year publication summary
19
|
9
|
9
|
10
|
6
|
10
|
12
|
11
|
9
|
1
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Cephalon LLC | 92 |
8 |
Cephalon, Inc. | 121 |
5 |
Purdue Pharmaceutical Products L.P. | 28 |
5 |
Bristol-myers Squibb Company | 4863 |
4 |
Drexel University | 972 |
4 |
Gilead Sciences, Inc. | 1951 |
4 |
Jiangsu Hengrui Medicine Co., Ltd. | 760 |
4 |
Kinki University | 235 |
4 |
Nippon Chemiphar Co., Ltd. | 236 |
4 |
Rutgers, The State University of New Jersey | 1844 |
4 |
LG Chem, Ltd. | 17639 |
3 |
Abbvie Inc. | 1782 |
3 |
Canopy Growth Corporation | 262 |
3 |
Fresenius Kabi Oncology Limited | 64 |
3 |
Shanghai Hengrui Pharmaceutical Co., Ltd. | 627 |
3 |
Boehringer Ingelheim International GmbH | 4754 |
2 |
Janssen Pharmaceutica N.V. | 3612 |
2 |
FUJIFILM Corporation | 28805 |
2 |
Mayo Foundation for Medical Education and Research | 3115 |
2 |
Connexios Life Sciences Pvt. Ltd. | 13 |
2 |
Other owners | 114 |